Latest Development Programs News

Black Bear Minerals has completed the acquisition of the high-grade Shafter Silver Project in Texas, including $150 million in existing infrastructure, positioning itself strategically amid rising silver demand and geopolitical supply shifts.

Abacus Group reported a solid FY25 with modest growth in funds from operations and stable distributions, underpinned by strong leasing activity and a diversified commercial portfolio. The Group also highlighted significant progress in sustainability and reaffirmed its FY26 guidance amid improving market conditions.

Wildcat Resources has significantly extended its Bolt Cutter Central lithium discovery in Western Australia's Pilbara, with drilling confirming a strike length of at least 900 meters and ongoing assays promising further growth. Concurrently, high-grade gold and antimony intercepts at the Mount Adrah project in NSW reinforce the company's diversified exploration success.

Biotron Limited has launched a $1.5 million non-renounceable rights issue to fund its strategic acquisition of Sedarex Limited and support ongoing drug development programs. The capital raise follows shareholder approval and aims to diversify Biotron’s portfolio with a next-generation general anaesthetic.

Beacon Minerals has declared a fully franked dividend of $0.05 per share, reflecting its robust cash position and confidence in ongoing growth projects. The dividend combines a regular and special payout, signalling strong financial health amid advancing operations.

Tryptamine Therapeutics has enrolled its second patient in a pioneering clinical trial using IV-infused psilocin to treat Binge Eating Disorder, with first dosing scheduled for December and results expected early next year.

Critical Resources Limited has secured a 12-month exclusive option to evaluate advanced solid-state lithium-ion battery technology from the South Dakota School of Mines & Technology, aiming to enhance battery safety, performance, and commercial potential.

Adisyn Ltd has successfully validated a critical pre-clean sub-process in its proprietary low-temperature graphene deposition method, marking a significant technical milestone toward revolutionizing semiconductor interconnects.

Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.

AXP Energy reports encouraging early oil and gas flowback at its Charlie #1 well in Oklahoma, marking a key milestone in its Mississippi Lime development program.

Radiopharm Theranostics has successfully enrolled the second cohort in its Phase 1 trial of 177Lu-RAD204, with the Data Safety Monitoring Committee greenlighting a dose increase to 90mCi for the third cohort. Early results show promising tumor targeting and safety in multiple advanced cancers.

HMC Digital Infrastructure Ltd’s DigiCo REIT has surpassed its IPO guidance with strong growth in contracted IT capacity and accelerated development projects in Australia and the US, positioning itself for a $180 million EBITDA run-rate by July 2026.